Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast canc
about
Acetylation-dependent oncogenic activity of metastasis-associated protein 1 co-regulatorMTA1, a transcriptional activator of breast cancer amplified sequence 3Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression dataExtranuclear coactivator signaling confers insensitivity to tamoxifenGene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in miceBreast Tumor Angiogenesis and Tumor-Associated Macrophages: Histopathologist's PerspectiveBevacizumab in the treatment of patients with advanced breast cancer: where have we landed?Estimation of immunohistochemical expression of VEGF in ductal carcinomas of the breast.Cytoplasmic estrogen receptor in breast cancer.The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients.Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer.Combination therapy with aromatase inhibitors: the next era of breast cancer treatment?Late recurrence of breast carcinoma metastasis to the hypopharynx: a case reportLoss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancerCurrent status of cediranib: the rapid development of a novel anti-angiogenic therapy.High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancerVisualization of angiogenesis during cancer development in the polyoma middle T breast cancer model: molecular imaging with (R)-[11C]PAQThe Impact of Ramucirumab on Survival in Patients with Advanced Solid Tumors: A Systematic Review and Meta-Analysis of Randomized II/III Controlled Trials.Overexpression of cofilin correlates with poor survival in breast cancer: A tissue microarray analysis.Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence.Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model.Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer.Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer.Overexpression of Gli1 in cancer interstitial tissues predicts early relapse after radical operation of breast cancer.Estrogen receptor-alpha phosphorylation at serine-118 and tamoxifen response in breast cancer.Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel.Molecular mechanisms of hormone resistance of breast cancer.
P2860
Q24292880-FF1331A7-04B0-44D4-B791-08CFA2DC578DQ24546715-7149DDBB-7794-4E55-9080-6AA201D04A68Q24684071-2AA05382-6966-460C-AF25-C3EDB7090F09Q28246263-B09026DA-D5D5-427F-946D-3D479358076BQ34245416-BE175727-5D70-4D61-A851-68692F69FBD2Q35055683-ECF04BAC-138E-4A55-8624-298659786CB4Q35076287-677014D2-85CD-4474-A3D8-E32CC81D0FB4Q35681760-EB1D1BD6-892E-4300-9555-A9D7D7288EE0Q35686728-9697F72F-779D-4B1E-B993-547D722F1238Q35813009-A3D29F4D-0872-4070-9064-3D53E4B5031EQ36458731-1A813B3E-6C1F-4413-BE4E-D6E61B593111Q36574547-80434B58-A6C4-42E5-9C60-AB62125E93E2Q36894951-20FF6218-9FC0-4E64-8BF4-D123E3E2979AQ37083038-3F5BF377-8B4F-448A-802B-2BA18BFB4B44Q37486753-0FBD0E26-5429-44F1-88E7-B389B7B3B5D2Q37601713-90F05BF7-8F60-4289-9D11-99355A2E59AFQ37703054-57B6EC06-77FF-4BB8-89AD-5AD60FA6FF80Q38627686-E9C2ABE3-3615-4556-8159-CF79A8BD88E0Q38637991-95F627AB-D6CD-472A-9113-3E1D04D122F8Q38916801-7C17ECE5-B824-4DCC-8ACE-EAB38C204CBEQ39979176-39B7CEA2-A743-44A6-A1EB-924EC59C104AQ40513874-CE852594-3603-47AC-9921-DDBCFE40592FQ42525415-FB81EA75-C93C-4A72-91E1-262F03F2551FQ42911630-FB521114-47DD-4C02-8F98-3F22029855BBQ43235318-C17E4150-B140-4BE1-AFC0-5F1CF1E4B8A6Q47418219-6F6BB961-73D0-4910-9296-7471E12E3ABEQ53086084-3C185889-0CB3-448A-BA08-45BB7651BF04
P2860
Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast canc
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Tumor-specific expression of v ...... n in premenopausal breast canc
@en
Tumor-specific expression of v ...... n in premenopausal breast canc
@nl
type
label
Tumor-specific expression of v ...... n in premenopausal breast canc
@en
Tumor-specific expression of v ...... n in premenopausal breast canc
@nl
prefLabel
Tumor-specific expression of v ...... n in premenopausal breast canc
@en
Tumor-specific expression of v ...... n in premenopausal breast canc
@nl
P2093
P356
P1476
Tumor-specific expression of v ...... n in premenopausal breast canc
@en
P2093
Bo Nordenskjöld
Göran Landberg
Lisa Rydén
Mårten Fernö
Per-Ebbe Jönsson
Pär-Ola Bendahl
Sten Thorstenson
P304
P356
10.1200/JCO.2005.08.126
P407
P577
2005-07-01T00:00:00Z